###begin article-title 0
###xml 54 59 <span type="species:ncbi:10090">mouse</span>
A novel myelin P0-specific T cell receptor transgenic mouse develops a fulminant autoimmune peripheral neuropathy
###end article-title 0
###begin p 1
H. Bour-Jordan and J.A. Bluestone contributed equally to this paper.
###end p 1
###begin p 2
###xml 145 146 145 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 303 304 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 370 371 370 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1162 1163 1158 1159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1169 1170 1165 1166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 696 701 <span type="species:ncbi:10090">mouse</span>
###xml 901 905 <span type="species:ncbi:10090">mice</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
Autoimmune-prone nonobese diabetic mice deficient for B7-2 spontaneously develop an autoimmune peripheral neuropathy mediated by inflammatory CD4+ T cells that is reminiscent of Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. To determine the etiology of this disease, CD4+ T cell hybridomas were generated from inflamed tissue-derived CD4+ T cells. A majority of T cell hybridomas were specific for myelin protein 0 (P0), which was the principal target of autoantibody responses targeting nerve proteins. To determine whether P0-specific T cell responses were sufficient to mediate disease, we generated a novel myelin P0-specific T cell receptor transgenic (POT) mouse. POT T cells were not tolerized or deleted during thymic development and proliferated in response to P0 in vitro. Importantly, when bred onto a recombination activating gene knockout background, POT mice developed a fulminant form of peripheral neuropathy that affected all mice by weaning age and led to their premature death by 3-5 wk of age. This abrupt disease was associated with the production of interferon gamma by P0-specific T cells and a lack of CD4+ Foxp3+ regulatory T cells. Collectively, our data suggest that myelin P0 is a major autoantigen in autoimmune peripheral neuropathy.
###end p 2
###begin p 3
###xml 493 494 493 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 697 698 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 1095 1096 1095 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 1266 1267 1266 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 1286 1287 1286 1287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1440 1441 1436 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 1443 1444 1439 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 956 960 <span type="species:ncbi:10090">mice</span>
###xml 1020 1024 <span type="species:ncbi:10090">mice</span>
###xml 1110 1114 <span type="species:ncbi:10090">mice</span>
###xml 1382 1386 <span type="species:ncbi:10090">mice</span>
###xml 1562 1566 <span type="species:ncbi:10090">mice</span>
###xml 1712 1717 <span type="species:ncbi:10090">mouse</span>
Guillain-Barre syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) are autoimmune diseases characterized by inflammatory demyelinating lesions of the peripheral nervous system (PNS) that cause devastating neurological deficits and paralysis. Multifocal demyelination associated with perivascular mononuclear cell infiltrates in the PNS is the pathological hallmark of GBS and CIDP, and autoreactive T and B cell responses are believed to be essential in both diseases (1). Defining self-antigens targeted by the autoimmune response can lead to a better understanding of the immunopathology of the disease and can potentially lead to antigen-specific tolerogenic therapies (2); however, progress has been limited by the paucity of animal models. We previously described the first spontaneous model of autoimmune disease of the PNS, called spontaneous autoimmune peripheral polyneuropathy, in autoimmune-prone nonobese diabetic (NOD) mice deficient for the co-stimulatory molecule B7-2 (NOD-B7-2KO mice) or mimicked many pathophysiological characteristics of GBS and CIDP (3). NOD-B7-2KO mice exhibit a progressive and generalized limb paralysis associated with severe demyelination and axonal damage caused by an autoimmune attack of the PNS (3). Inflammatory CD4+ T cells are essential for the development of autoimmune peripheral neuropathy, and NOD-B7-2KO mice deficient for IFN-gamma were protected from disease (3, 4). In this report, we examined the antigen specificity of autoreactive T cells infiltrating the nerves of neuropathic mice and found that myelin protein 0 (P0) is a dominant self-antigen recognized by T cells and autoantibodies. We generated a TCR transgenic (TCR-Tg) mouse specific for a P0 epitope and demonstrated that these T cells were sufficient to induce a fulminant form of peripheral neuropathy.
###end p 3
###begin title 4
RESULTS AND DISCUSSION
###end title 4
###begin title 5
Generation of peripheral nerve-specific T cell hybridomas
###end title 5
###begin p 6
###xml 35 36 35 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 251 252 251 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 335 341 335 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 467 475 467 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 478 479 478 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 329 333 <span type="species:ncbi:10090">mice</span>
We previously demonstrated that CD4+ T cells from neuropathic NOD-B7-2KO mice could transfer disease, suggesting that the site of infiltration and tissue destruction would be enriched in pathogenic autoreactive T cells specific for nerve antigens. CD4+ T cells were isolated from the infiltrated nerves of neuropathic NOD-B7-2KO mice (Fig. 1) and were expanded with anti-CD3 and anti-CD28 mAbs, and IL-2 by 20-100-fold after 2 wk in culture, as previously described (Fig. 1 B) (5).
###end p 6
###begin p 7
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Generation of peripheral nerve&#8211;specific T cell hybridoma.</bold>
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 235 236 235 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 382 383 382 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 435 436 435 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
Generation of peripheral nerve-specific T cell hybridoma. (A and B) CD4+ T cells were sorted from the nerves of neuropathic NOD-B7-2KO mice (A) and expanded in vitro (B). Data are representative of 15 sorts and expansions. (C) 2-5 x 106 expanded cells were transferred into NOD-SCID or NOD-RAGKO immunodeficient mice, and recipients were followed for the development of neuropathy (n = 5 mice from two independent experiments). (D) CD4+ T cell hybridomas were stimulated with APCs alone (open histogram) or in the presence of the indicated stimulus (shaded histograms), and CD69 up-regulation was assessed. Clone 2E7 is shown. Data are representative of four experiments.
###end p 7
###begin p 8
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 34 35 34 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 107 115 107 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 147 148 147 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 188 189 188 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 265 266 265 266 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 270 271 270 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 451 452 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 616 624 616 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 891 892 891 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 537 541 <span type="species:ncbi:10090">mice</span>
###xml 823 827 <span type="species:ncbi:10090">mice</span>
Transfer of 2-5 x 106 expanded CD4+ T cells into immunodeficient recipients led to neuropathy within 5 wk (Fig. 1 C and not depicted). Expanded CD4+ T cells from nerves were fused with TCR- BW1100 cells (6) to generate antigen-specific T cell hybridomas. Stable CD4+ TCR+ T cell hybridomas, responsive to anti-CD3 stimulation, were tested further for their ability to be activated by protein lysates prepared from sciatic nerves. A small subset of CD4+ T cell hybridomas (11 out of 56) derived from the infiltrated nerves of neuropathic mice responded to sciatic nerve antigens as measured by up-regulation of CD69 (Fig. 1 D). 1 out of these 11 hybridoma responded to an antigen shared between the PNS and central nervous system (CNS; Table S1, available at ), supporting the previous finding that neuropathy in NOD-B7-2KO mice preferentially targeted the PNS without affecting CNS tissues (3). As expected, up-regulation of CD69 on T cell hybridomas in response to nerve lysate was inhibited in the presence of anti-MHC class II blocking mAbs (Fig. S1), confirming that the response of T cell hybridomas to nerve antigens was dependent on recognition of a peptide-MHC class II complex.
###end p 8
###begin title 9
###xml 40 41 40 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Antigen specificity of nerve-derived CD4+ T cell hybridomas
###end title 9
###begin p 10
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 422 430 410 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 936 944 924 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 1217 1225 1205 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 1434 1442 1422 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 235 239 <span type="species:ncbi:10090">mice</span>
###xml 345 349 <span type="species:ncbi:10090">mice</span>
###xml 930 934 <span type="species:ncbi:10090">mice</span>
Neural proteins targeted by autoantibodies in NOD-B7-2KO mice were determined to identify potential targets of autoreactive T cells (7, 8). Protein extracts prepared from the sciatic nerve were immunoblotted with sera from neuropathic mice (4). The majority of sera (27 out of 50; 54%) from individual neuropathic T reg cell-depleted NOD-B7-2KO mice reacted strongly against an antigen migrating at approximately25-30 kD (Fig. 2 A). Immunoprecipitation was performed on columns containing protein G agarose coupled to sera from neuropathic animals, followed by peptide mass fingerprinting, and unequivocally identified the 28-kD protein P0, a major component of the myelin sheath expressed exclusively in the PNS but not in the CNS. 6 out of 11 hybridomas that were activated by peripheral nerve lysate up-regulated CD69 in the presence of P0 peptides, suggesting that P0 is a major autoantigen targeted by T cells in neuropathic mice (Fig. 2 B). Of these six P0-specific hybridomas, four recognized P0 peptides in the putatively extracellular portion of the protein (peptide pool #1), whereas the other two hybridomas were specific for P0 peptides located in the cytoplasmic portion of the protein (peptide pool #4; Fig. 2 B). Three out of the four extracellular P0-specific hybridomas were responsive to the same P0 peptide (amino acids 1-25), suggesting the presence of an immunodominant epitope in this portion of the P0 protein (Fig. 2 C and not depicted). We should emphasize that the four hybridomas specific for P0 1-25 were generated from distinct T cell clones, because the TCR Valpha and Vbeta combination was unique to each hybridoma (Table S1).
###end p 10
###begin p 11
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Myelin P0 is targeted by the autoimmune response in NOD-B7-2KO mice.</bold>
###xml 447 448 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 508 516 508 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 182 186 <span type="species:ncbi:10090">mice</span>
###xml 219 223 <span type="species:ncbi:10090">mice</span>
Myelin P0 is targeted by the autoimmune response in NOD-B7-2KO mice. (A) Immunoblotting of sciatic nerve extracts with serum from individual anti-B7-1-treated NOD-B7-2KO neuropathic mice (lanes 1-9), nonneuropathic NOD mice (lanes 10 and 11), or BALB/c controls (lanes 12 and 13). Data are representative of five to nine independent experiments for each serum. The predominant 25-30-kD reactivity is indicated with an arrow. (B) Nerve-specific CD4+ T cell hybridomas were examined for reactivity to P0 as in Fig. 1 D, using pools of overlapping peptides spanning the P0 protein. Data are representative of two experiments. Arrows indicate reactive clones to a specific pool of peptide. (C) Activation of the 2E7 hybridoma by individual P0 peptides from pools #1 and #4. Data are representative of two experiments.
###end p 11
###begin title 12
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
Generation of a myelin P0-specific TCR-Tg (POT) mouse
###end title 12
###begin p 13
###xml 236 244 222 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 640 648 622 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 699 707 681 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 840 848 822 830 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 877 878 859 860 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 899 900 878 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1049 1050 1024 1025 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1079 1080 1051 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1104 1105 1073 1074 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1137 1138 1106 1107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1470 1471 1435 1436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 1755 1758 1716 1719 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1769 1772 1730 1733 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1914 1916 1875 1877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 2065 2066 2026 2027 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2073 2074 2031 2032 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2096 2097 2054 2055 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2104 2105 2059 2060 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2175 2178 2126 2129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 2185 2193 2136 2144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 2564 2565 2515 2516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2752 2753 2703 2704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2836 2844 2787 2795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 2859 2860 2810 2811 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2866 2867 2817 2818 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 2946 2954 2897 2905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 834 838 <span type="species:ncbi:10090">mice</span>
###xml 922 926 <span type="species:ncbi:10090">mice</span>
###xml 983 987 <span type="species:ncbi:10090">mice</span>
###xml 1191 1195 <span type="species:ncbi:10090">mice</span>
###xml 1408 1412 <span type="species:ncbi:10090">mice</span>
###xml 1490 1494 <span type="species:ncbi:10090">mice</span>
###xml 1773 1777 <span type="species:ncbi:10090">mice</span>
###xml 2000 2004 <span type="species:ncbi:10090">mice</span>
###xml 2052 2056 <span type="species:ncbi:10090">mice</span>
###xml 2179 2183 <span type="species:ncbi:10090">mice</span>
###xml 2485 2489 <span type="species:ncbi:10090">mice</span>
###xml 2592 2596 <span type="species:ncbi:10090">mice</span>
###xml 2807 2811 <span type="species:ncbi:10090">mice</span>
###xml 2940 2944 <span type="species:ncbi:10090">mice</span>
###xml 3042 3046 <span type="species:ncbi:10090">mice</span>
Next, we generated a POT mouse by cloning the rearranged TCR alpha (Valpha9) and beta (Vbeta11) chains from hybridoma 2E7, which was strongly activated in response to peripheral nerve lysate and P0 immunodominant peptide 1-25 in vitro (Fig. 2 C). The POT mice showed no difference in the total cell numbers of the spleen cells or thymocytes as compared with non-Tg littermates (unpublished data). The percentages of CD4 and CD8 single-positive cells were decreased in the thymus in POT mice as compared with control littermates, and the CD4/CD8 ratio was slightly increased (4.9 +/- 0.8% compared with 3.6 +/- 0.2%, respectively; P < 0.05; Fig. 3 A, left). Similar data were observed in the spleen (Fig. 3 A, right). Analysis of TCR expression confirmed the expression of the Tg TCR and showed very efficient allelic exclusion in POT mice (Fig. 3 A, right). Indeed, >90% of CD4+ T cells were Vbeta11+ in the spleen of POT mice versus <10% in non-Tg littermates (90.6 +/- 5.4% in POT mice versus 6.5 +/- 0.5% in controls). Conversely, POT splenic CD4+ T cells contained <2% Vbeta8+ T cells, whereas Vbeta8+ T cells represented >20% of CD4+ T cells in control littermates (1.2 +/- 1.3% in POT mice versus 22.8 +/- 1.2% in controls). These results suggested that T cells expressing the POT TCR were positively selected to generate a normal population of mature T cells in the periphery, similar to other TCR-Tg mice specific for autoantigens such as islet-specific BDC2.5 (9). Analysis of POT mice, crossed onto a RAGKO background to eliminate the potential influence of endogenous TCR alpha chains on the thymic selection, confirmed that TCR-Tg T cells were positively selected in the thymus, although the cell numbers were greatly reduced compared with RAG+/- or POT-RAG+/- mice (Fig. S2, available at ), suggesting a more effective negative selection induced by P0-expressing thymic stromal cells in this setting (10). Although the total spleen cell number was reduced in POT-RAGKO compared with POT mice, the majority of mature T cells from POT-RAGKO mice were CD4+Vbeta11+ T cells, with few CD8+Vbeta11+ T cells (a mean ratio of 10.6 +/- 1.2% versus 3.7 +/- 0.3% in POT-RAG+/- mice; Fig. 3 B and Fig. S2). Thus, P0-specific POT TCR-Tg T cells successfully survived thymic selection to generate a population of mature autoreactive T cells in the periphery even on a RAGKO background. Finally, we examined the presence of T reg cells and the activation status of TCR-Tg T cells in POT mice. There was no difference in the expression of CD69, CD62L, and CD44 on CD4+ T cells isolated from POT mice compared with non-Tg littermates (unpublished data), showing that POT T cells were not activated in the periphery. Furthermore, a similar percentage of CD4+ T cells expressed the T reg cell marker Foxp3 in POT mice compared with controls (Fig. 3 C). However, CD4+ Foxp3+ T reg cells could not be detected in the spleen and thymus of POT-RAGKO mice (Fig. 3 D; and Figs. S3 and S4), thus confirming that the thymic selection of T reg cells in POT mice involved TCRs using endogenous alpha chains.
###end p 13
###begin p 14
###xml 0 39 0 39 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Phenotypic analysis of POT TCR-Tg mice.</bold>
###xml 62 63 62 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 217 218 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 368 369 368 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 417 418 417 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 494 495 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 266 270 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
Phenotypic analysis of POT TCR-Tg mice. (A) Phenotyping of CD4+ and CD8+ T cells in the thymus (left) and spleen (right) of NOD-POT TCR-Tg mice (top) and transgene-negative littermates (bottom). (B) Phenotyping of CD4+ T cells in the spleens of NOD-RAGKO-POT TCR-Tg mice. (C) Foxp3 expression in the spleens of the indicated 12-wk-old mice (histograms are gated on CD4+ T cells). Numbers indicate percentages of Foxp3+ cells in the CD4 population. (A-C). (D) CD25 and Foxp3 expression among CD4+ cells in the spleens of the indicated 19-d-old mice. Percentages +/- SD are indicated. Data are representative of two or more experiments.
###end p 14
###begin title 15
Proliferation and cytokine production of P0-specific TCR-Tg T cells
###end title 15
###begin p 16
###xml 7 8 7 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 171 179 171 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 776 784 776 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 1065 1073 1065 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 1076 1078 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 1255 1263 1251 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 1570 1578 1558 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 D</xref>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
###xml 1368 1372 <span type="species:ncbi:10090">mice</span>
POT CD4+ T cells proliferated strongly in response to protein extracts prepared from sciatic nerves but not spinal cord or brain, confirming their strict PNS specificity (Fig. 4 A). Furthermore, POT T cells displayed a similarly strong proliferation when cultured with P0 protein (including the P0 peptide 1-25) but not with another myelin protein (P2), confirming the P0 specificity and demonstrating that the T cells are fully functional and not anergic in the periphery. We examined the capacity of activation of PNS-specific autoreactive T cells to proliferate in NOD (resistant) versus NOD-B7-2KO (susceptible) mice. POT T cells proliferated extensively in several lymph nodes in NOD-B7-2KO but not NOD recipients, including brachial, axillary, and inguinal lymph nodes (Fig. 4 B; and Fig. S5, available at ), illustrating a clear dichotomy between NOD and NOD-B7-2KO mice, as the development of diabetes versus neuropathy directly correlates with the ability of islet versus nerve antigen-specific autoreactive T cells to proliferate in relevant lymph nodes (Fig. 4 B) (11). Finally, we detected high levels of IFN-gamma and IL-17 in the culture supernatant of POT T cells upon in vitro stimulation in the absence of any skewing culture conditions (Fig. 4 C). Surprisingly, intracellular cytokine staining revealed that 40-50% of T cells isolated from POT-RAGKO mice produced IFN-gamma but no IL-17 ex vivo, whereas only 2.5% of POT T cells on a RAG-sufficient background produced IFN-gamma and <1% produced IL-17, similar to what was observed in NOD littermates (Fig. 4 D). This result suggested that cytokine production observed in a RAG-sufficient background was influenced by endogenous TCR alpha chains and/or regulatory cell populations that could limit the activation and differentiation of autoreactive POT T cells.
###end p 16
###begin p 17
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Proliferation and cytokine production of P0-specific NOD-POT T cells.</bold>
###xml 253 254 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 447 448 447 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 451 452 451 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 745 746 737 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
Proliferation and cytokine production of P0-specific NOD-POT T cells. (A) Proliferation of CFSE-labeled NOD-POT T cells in the presence of APCs alone (gray histogram) or APCs and the indicated stimulus (black histograms). Histograms are gated on the CD4+ population. (B) Proliferation of CFSE-labeled NOD-POT spleen cells in NOD or NOD-B7-2KO recipients (22 wk of age) after 4 d (inguinal lymph nodes are shown). Histograms are gated on the Thy1.1+CD4+ population. (C) Production of IFN-gamma (left) and IL-17 (right) in the culture supernatant of NOD-POT cells activated by the indicated stimulus. (D) Production of IFN-gamma and IL-17 after stimulation of spleen cells from the indicated mice with PMA and ionomycin. Dot plots are gated on CD4+ T cells. Numbers indicate percentages of cells in the quadrants. Data are representative of two or more experiments.
###end p 17
###begin title 18
Pathogenicity of P0-specific TCR-Tg T cells in vivo
###end title 18
###begin p 19
###xml 108 116 108 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 256 264 256 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 619 620 619 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 625 626 625 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 778 786 778 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 929 944 929 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, B and C</xref>
###xml 1094 1109 1094 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, C and D</xref>
###xml 1257 1265 1257 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 1358 1359 1358 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 1471 1486 1471 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5, A and E</xref>
###xml 1711 1719 1711 1719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 1794 1795 1794 1795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1919 1927 1919 1927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 F</xref>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 672 676 <span type="species:ncbi:10090">mice</span>
###xml 727 731 <span type="species:ncbi:10090">mice</span>
###xml 820 824 <span type="species:ncbi:10090">mice</span>
###xml 1071 1075 <span type="species:ncbi:10090">mice</span>
###xml 1352 1356 <span type="species:ncbi:10090">mice</span>
###xml 1465 1469 <span type="species:ncbi:10090">mice</span>
###xml 1586 1590 <span type="species:ncbi:10090">mice</span>
###xml 1850 1855 <span type="species:ncbi:10090">mouse</span>
###xml 2149 2153 <span type="species:ncbi:10090">mice</span>
###xml 2222 2226 <span type="species:ncbi:10090">mice</span>
Although mononuclear infiltration could be detected in the nerves of some POT mice as early as 3 wk of age (Fig. 5 A), many POT mice did not show any sign of inflammation in sciatic nerves or clinically detectable peripheral neuropathy by 15-17 wk of age (Fig. 5 A and not depicted). However, adoptive transfer of in vitro-activated or CD25-depleted POT T cells led to peripheral nerve infiltration and induced neuropathy in immunodeficient recipients (unpublished data). These results suggested that the lack of spontaneous neuropathy in POT mice may have been a consequence of increased numbers of antigen-specific Tg+Foxp3+ T reg cells as compared with Tg-negative NOD mice. Thus, we examined T reg cell-deficient POT-RAGKO mice for tissue infiltration and clinical disease (Fig. 3 D; and Figs. S3 and S4). POT-RAGKO mice displayed a dramatic phenotype characterized by early weight loss and premature death by 3-5 wk of age (Fig. 5, B and C; and not depicted), and spontaneously developed a fulminant form of neuropathy that started as early as 18 d and affected all mice by 3-4 wk of age (Fig. 5, C and D). The spontaneous peripheral neuropathy induced by POT T cells led to motor dysfunction indicated by clasping of the limbs and difficulty walking (Fig. 5 C; and Videos 1-3, available at ), similar to what we originally observed in NOD-B7-2KO mice (3). Development of neuropathy was accompanied by a heavy infiltrate in the sciatic nerves of NOD-RAGKO-POT mice (Fig. 5, A and E), as well as myelin destruction (Fig. S6). The infiltration in the sciatic nerves of NOD-RAGKO-POT mice was strikingly higher than in their RAG-sufficient counterparts at 3-4 wk of age (P = 0.01 using a Mann-Whitney U test; Fig. 5 A), correlating with clinical disease. Indeed, adoptive transfer of 1.3 x 106 splenocytes from a 25-d-old neuropathic NOD-RAGKO-POT mouse induced severe neuropathy in all NOD-SCID recipients in <2 wk (Fig. 5 F). Finally, the peripheral neuropathy induced by P0-specific POT TCR-Tg T cells was extremely severe and led to death of the animals, usually within 24 h after clinical disease onset, either spontaneously in NOD-RAGKO-POT mice or after adoptive transfer of T cells from NOD-RAGKO-POT or NOD-POT mice (unpublished data).
###end p 19
###begin p 20
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Spontaneous development of a fulminant form of neuropathy in NOD-RAGKO-POT mice.</bold>
###xml 792 793 786 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 75 79 <span type="species:ncbi:10090">mice</span>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 239 243 <span type="species:ncbi:10090">mice</span>
###xml 412 417 <span type="species:ncbi:10090">mouse</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
Spontaneous development of a fulminant form of neuropathy in NOD-RAGKO-POT mice. (A) Quantification of infiltration in the nerves of indicated mice at 3-4 wk of age. Horizontal bars indicate means. *, P < 0.05. (B) Weight in the indicated mice as a function of age. Results represent cumulated data from two different experiments. Data are means +/- SEM. (C) Clasping phenotype in a representative NOD-RAGKO-POT mouse compared with the normal plantar reaction in a NOD-RAGKO littermate, and weight deficit in NOD-RAGKO-POT mice at 3-4 wk of age. (D) Neuropathy in the indicated mice as a function of age. (E) Intense infiltrate in the sciatic nerve of NOD-RAGKO-POT mice. Bars, 250 microm. (F) Adoptive transfer of neuropathy by spleen cells from NOD-RAGKO-POT mice into NOD-SCID recipients (n = 4). Data are representative of two independent transfers. Videos 1-3 are available at .
###end p 20
###begin p 21
###xml 288 289 288 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 748 749 748 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 1236 1238 1236 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 1239 1241 1239 1241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 1365 1367 1365 1367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 1554 1556 1554 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 1638 1640 1638 1640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
###xml 1967 1969 1967 1969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 1971 1973 1971 1973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
###xml 2060 2062 2060 2062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 2212 2214 2212 2214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 2549 2551 2549 2551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 2857 2865 2857 2865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 142 147 <span type="species:ncbi:10090">mouse</span>
###xml 255 259 <span type="species:ncbi:10090">mice</span>
###xml 625 629 <span type="species:ncbi:10118|species:ncbi:10116">rats</span>
###xml 634 638 <span type="species:ncbi:10090">mice</span>
###xml 972 980 <span type="species:ncbi:9606">patients</span>
###xml 1068 1075 <span type="species:ncbi:9606">patient</span>
###xml 1202 1210 <span type="species:ncbi:9606">patients</span>
###xml 1355 1363 <span type="species:ncbi:9606">patients</span>
###xml 1500 1508 <span type="species:ncbi:9606">patients</span>
###xml 1628 1636 <span type="species:ncbi:9606">patients</span>
###xml 1936 1944 <span type="species:ncbi:9606">patients</span>
###xml 1960 1965 <span type="species:ncbi:10090">mouse</span>
###xml 2047 2052 <span type="species:ncbi:10090">mouse</span>
###xml 2108 2112 <span type="species:ncbi:10090">mice</span>
###xml 2338 2342 <span type="species:ncbi:10090">mice</span>
###xml 2602 2606 <span type="species:ncbi:10090">mice</span>
Collectively, our data demonstrate that myelin P0 is a major autoantigen targeted by autoantibodies and autoreactive T cells in a spontaneous mouse model of peripheral neuropathy. Importantly, the development of an abrupt form of disease in NOD-RAGKO-POT mice reveals that P0-specific CD4+ T cells were sufficient to induce catastrophic damage in the PNS and suggests that P0-specific T cells could play a central role in inducing tissue destruction in autoimmune neuropathy. P0 is a major component of the PNS that represents >50% of the peripheral myelin protein content. Experimental autoimmune neuritis can be induced in rats and mice by immunization with P0 protein or peptides in adjuvant or by adoptive transfer of P0-specific T cell lines (1). However, these models involve active immunization and powerful adjuvants, which does not mirror the spontaneous disease in individuals genetically prone to autoimmunity. Reports of immune responses to P0 in GBS and CIDP patients have generated conflicting results that could be explained by different techniques and patient populations. Nevertheless, of all neural proteins tested, P0 has been the most consistent reactivity detected in the serum of patients with active GBS or CIDP (12-14). Khalili-Shirazi et al. initially reported proliferative responses to P0 protein or peptides in 9 out of 19 GBS patients (15). More recently, P0-specific T cell responses measured by proliferation or ELISPOT were not statistically different in GBS and CIDP patients as compared with nonautoimmune neuropathies (16), whereas another report described P0-specific IL-10 production in GBS patients (17), raising the possibility that immune responses to P0 may be regulatory rather than pathogenic. These findings were reminiscent of the glutamic acid decarboxylase 65-kD isoform (GAD65) autoantigen in type 1 diabetes. Similar to P0, autoantibodies to GAD were readily detected in type 1 diabetes patients and in the NOD mouse (18, 19), and GAD-specific T cells could adoptively transfer diabetes in the NOD mouse model (20). However, GAD-specific TCR-Tg or retrogenic mice revealed that GAD-specific T cells did not induce diabetes but rather exerted a protective effect (21). In contrast, our report of an aggressive form of peripheral neuropathy spontaneously occurring in P0-specific POT TCR-Tg mice strengthens the potential role of P0 as a central autoantigen involved in disease development and tissue damage in autoimmune neuropathy. While this paper was being reviewed, Kim et al. published a report (22) showing that autoimmune neuropathy in NOD-B7-2KO mice could be prevented by tolerance induction using a specific P0 peptide. Although the peptide specificity (P0 180-199) was different from the POT TCR epitope (P0 1-25), the epitope overlapped with two of our peripheral nerve-specific hybridoma clones (Fig. 2 B; and Table S2, available at ). In their report, the adoptive transfer of a P0-specific line only led to very mild disease (grade 1). The difference with our results may be because of the specificity differences or their use of a T cell line.
###end p 21
###begin p 22
###xml 227 228 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">4</xref>
###xml 346 347 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 351 352 335 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 429 431 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 433 435 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 576 578 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 674 676 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 1081 1083 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 221 225 <span type="species:ncbi:10090">mice</span>
###xml 305 313 <span type="species:ncbi:9606">patients</span>
###xml 419 427 <span type="species:ncbi:9606">patients</span>
###xml 664 672 <span type="species:ncbi:9606">patients</span>
Our results suggest that neuropathy induced by P0-specific POT T cells involves mainly IFN-gamma-producing Th1 cells in agreement with a central role of IFN-gamma in the development of peripheral neuropathy in NOD-B7-2KO mice (4). Furthermore, elevated serum levels of IFN-gamma have been reported in GBS patients, and the percentage of IFN-gamma+ CD4+ T cells was markedly increased in the cerebrospinal fluid of CIDP patients (23, 24). Th17 cells have been suggested to play a major role in multiple sclerosis and its animal model experimental autoimmune encephalomyelitis (25). Although increased levels of IL-17 have been described in the spinal fluid of CIDP patients (24), it is still unclear whether Th17 cells are important for autoimmune peripheral neuropathies. We found that low levels of IL-17 were produced by POT T cells on a RAG-sufficient background in vitro. It was recently reported that Th1 and Th17 cells may have different abilities to infiltrate the CNS and cause experimental autoimmune encephalomyelitis depending on the level of local tissue inflammation (26). Thus, our report does not preclude a role for IL-17 in spontaneous autoimmune peripheral polyneuropathy and other PNS autoimmune diseases but suggests that IFN-gamma is the dominant cytokine associated with peripheral neuropathy induced by P0-specific POT T cells.
###end p 22
###begin p 23
###xml 135 136 135 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 142 143 142 143 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 280 281 280 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 287 288 287 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 721 722 721 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 488 496 <span type="species:ncbi:9606">patients</span>
###xml 632 640 <span type="species:ncbi:9606">patients</span>
Another important insight revealed by our report is the control of P0-specific T cells and, hence, the development of neuropathy by CD4+ Foxp3+ T reg cells. Indeed, the development of the fulminant form of neuropathy in POT-RAGKO mice was associated with a complete absence of CD4+ Foxp3+ T reg cells, suggesting that antigen-specific T reg cells are key to controlling the disease. Because the percentage of T reg cells has been shown to be lower in the peripheral blood of GBS and CIDP patients (27-29), our findings suggest that immunotherapy using P0-specific T reg cells may be an important future therapeutic option for these patients, as similar treatments are now being developed for several autoimmune diseases (2).
###end p 23
###begin title 24
MATERIALS AND METHODS
###end title 24
###begin title 25

###end title 25
###begin title 26
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 26
###begin p 27
###xml 63 64 63 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 162 163 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 17 21 <span type="species:ncbi:10090">mice</span>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
NOD and NOD-SCID mice were purchased from Taconic. NOD-B7-2KO (3), NOD-TCRalphaKO, and NOD-RAG2KO mice were bred in our facility. Neuropathy was assessed weekly (3). All mice were housed in a specific pathogen-free University of California, San Francisco (UCSF) facility. All animal experiments were approved by the Institutional Animal Care and Use Committee of UCSF.
###end p 27
###begin title 28
Peripheral nerve-specific hybridomas.
###end title 28
###begin p 29
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 150 151 150 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 155 156 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 342 343 342 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 611 612 611 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 837 842 <span type="species:ncbi:9606">human</span>
###xml 874 879 <span type="species:ncbi:10090">mouse</span>
Cells from sciatic nerves of neuropathic NOD-B7-2KO mice were prepared as previously described (3), stained with CD4-FITC and CD8-allophycocyanin. CD4+ CD8- cells were sorted on a cytometer (MoFlo; Dako) and expanded with anti-CD3- and anti-CD28-coated beads supplemented with 2,000 IU/ml rhIL-2, as previously described (5). The expanded CD4+ T cells were fused to the TCR-negative thymoma partner BW1100 (provided by E. Palmer, University Hospital Basel, Basel, Switzerland) using standard protocols. TCR-expressing hybridoma clones were tested for antigen specificity by incubating 50,000 cells with 0.2 x 106 APCs (NOD-TCRalphaKO spleen cells, irradiated NOD spleen cells, or NOD BM-derived DCs) with the stimulus indicated in the figures for 16-24 h, followed by staining with CD69-PE. Overlapping peptides spanning the sequence of human P0 (which is 94% homologous to mouse P0 at the amino-acid level) were provided by N. Gregson (King's College London, London, England, UK; Table S2).
###end p 29
###begin title 30
###xml 25 29 <span type="species:ncbi:10090">mice</span>
Generation of POT TCR-Tg mice.
###end title 30
###begin p 31
###xml 236 238 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
The full-length coding sequences for the TCR alpha and beta chains were cloned by PCR from 2E7 hybridoma cDNA using the indicated primers (Table S3, available at ), and were subcloned into a CD2 and CD4 expression vector, respectively (30), allowing expression of the transgenes in both CD4 and CD8 T cells. Tg mice were generated by microinjection of CD2-TCRalpha and CD4-TCRbeta constructs into NOD embryos. Vectors were provided by N. Killeen (UCSF, San Francisco, CA).
###end p 31
###begin title 32
Statistical analysis.
###end title 32
###begin p 33
All statistical analyses were performed using an unpaired two-tailed Mann-Whitney U test with Prism software (GraphPad Software, Inc.). P </= 0.05 was considered significant.
###end p 33
###begin title 34
Online supplemental material.
###end title 34
###begin p 35
###xml 336 340 <span type="species:ncbi:10090">mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 508 512 <span type="species:ncbi:10090">mice</span>
###xml 586 591 <span type="species:ncbi:10090">mouse</span>
###xml 709 714 <span type="species:ncbi:10090">mouse</span>
Table S1 shows the characteristics of nerve-specific hybridomas. Tables S2 and S3 show the sequences of peptides and primers used in this report. Fig. S1 shows the inhibition of hybridoma activation by anti-MHC class II mAbs. Figs. S2-S4 show CD4, CD8, Vbeta, CD25, and Foxp3 FACS analysis of thymus and spleen cells from NOD-RAGKO-POT mice. Fig. S5 shows the enhanced proliferation of NOD-POT cells in NOD-B7-2KO mice compared with NOD recipients. Fig. S6 shows sciatic nerve demyelination in NOD-RAGKO-POT mice. Videos 1 and 2 show a grid test to assess neuropathy in a NOD-RAGKO-POT mouse and a NOD-RAGKO littermate, respectively. Video 3 shows the clasping phenotype and weight deficit in a NOD-RAGKO-POT mouse compared with the normal plantar reaction in a NOD-RAGKO littermate. Online supplemental material is available at .
###end p 35
###begin title 36
Supplementary Material
###end title 36
###begin title 37
[Supplemental Material Index]
###end title 37
###begin p 38
The authors wish to thank H. Lu and N. Killeen for the vectors and microinjections, C. Austin for histology, S. Jiang for cell sorting, D. Vignali and A. Burton for discussions, N. Gregson for providing P0 peptides, and A. Weishaupt and R. Gold for providing P0 and P2 recombinant proteins.
###end p 38
###begin p 39
This work was supported by National Institutes of Health grant R01 AI50834, a UCSF Research Evaluation and Allocation Committee grant, and a Neuropathy Association scientific research grant.
###end p 39
###begin p 40
The authors have no conflicting financial interests.
###end p 40
###begin article-title 41
Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system.
###end article-title 41
###begin article-title 42
Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease.
###end article-title 42
###begin article-title 43
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice.
###end article-title 43
###begin article-title 44
###xml 110 114 <span type="species:ncbi:10090">mice</span>
Distinct effector mechanisms in the development of autoimmune neuropathy versus diabetes in nonobese diabetic mice.
###end article-title 44
###begin article-title 45
In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes.
###end article-title 45
###begin article-title 46
###xml 56 61 <span type="species:ncbi:10090">mouse</span>
Physiologic expression of two superantigens in the BDF1 mouse.
###end article-title 46
###begin article-title 47
Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system.
###end article-title 47
###begin article-title 48
###xml 33 38 <span type="species:ncbi:9606">human</span>
Insulin as an autoantigen in NOD/human diabetes.
###end article-title 48
###begin article-title 49
Following a diabetogenic T cell from genesis through pathogenesis.
###end article-title 49
###begin article-title 50
Tolerance induction by intrathymic expression of P0.
###end article-title 50
###begin article-title 51
Costimulation controls diabetes by altering the balance of pathogenic and regulatory T cells.
###end article-title 51
###begin article-title 52
Antibodies to peripheral nerve myelin proteins in chronic inflammatory demyelinating polyradiculoneuropathy.
###end article-title 52
###begin article-title 53
Antibody responses to P0 and P2 myelin proteins in Guillain-Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy.
###end article-title 53
###begin article-title 54
P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy.
###end article-title 54
###begin article-title 55
T cell responses to myelin proteins in Guillain-Barre syndrome.
###end article-title 55
###begin article-title 56
###xml 65 73 <span type="species:ncbi:9606">patients</span>
T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
###end article-title 56
###begin article-title 57
Immune responses to myelin proteins in Guillain-Barre syndrome.
###end article-title 57
###begin article-title 58
###xml 95 99 <span type="species:ncbi:10090">mice</span>
Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.
###end article-title 58
###begin article-title 59
###xml 71 77 <span type="species:ncbi:10090">murine</span>
Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes.
###end article-title 59
###begin article-title 60
###xml 56 60 <span type="species:ncbi:10090">mice</span>
GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice.
###end article-title 60
###begin article-title 61
On the pathogenicity of autoantigen-specific T-cell receptors.
###end article-title 61
###begin article-title 62
Targeting of myelin protein zero in a spontaneous autoimmune polyneuropathy.
###end article-title 62
###begin article-title 63
###xml 91 99 <span type="species:ncbi:9606">patients</span>
Elevated serum levels of IFN-gamma, IL-4 and TNF-alpha/unelevated serum levels of IL-10 in patients with demyelinating diseases during the acute stage.
###end article-title 63
###begin article-title 64
Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF.
###end article-title 64
###begin article-title 65
Induction and effector functions of T(H)17 cells.
###end article-title 65
###begin article-title 66
Cutting Edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis.
###end article-title 66
###begin article-title 67
###xml 62 70 <span type="species:ncbi:9606">patients</span>
Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with Guillain-Barre syndrome.
###end article-title 67
###begin article-title 68
###xml 123 131 <span type="species:ncbi:9606">patients</span>
Increased levels of activated T-cells and reduced levels of CD4/CD25+ cells in peripheral blood of Guillain-Barre syndrome patients compared to controls.
###end article-title 68
###begin article-title 69
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Impairment of circulating CD4+CD25+ regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy.
###end article-title 69
###begin article-title 70
CD4 promotes breadth in the TCR repertoire.
###end article-title 70

